Glucagon and GLP-1 receptor dual agonism : a therapeutic approach for the treatment of obesity
Obesity is a growing global epidemic and current medical therapies have proven inadequate. Endogenous satiety hormones provide an attractive target for the development of drugs which aim to cause effective weight loss with minimal side effects. Two related peptide hormones, glucagon and glucagon-lik...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
Imperial College London
2015
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.739556 |